Intuitive Surgical's Shares Soared 9.34% After Earnings Release: Unveiling the Competitive Advantages of the Medical Robot Star
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $527 million, or $1.46 per diluted share, compared with $421 million, or $1.18 per diluted share, in the second quarter of 2023.
CereVasc Announces Appointments of New Directors
Medical Device Leaders Shlomi Nachman and Timothy Scannell to join Board of DirectorsBOSTON, July 16, 2024 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel
Stryker Is Maintained at Buy by BTIG
Stryker Is Maintained at Buy by
Express News | Stryker Corporation : Morgan Stanley Raises Target Price to $350.00 From $345.00
Morgan Stanley Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $350
Morgan Stanley analyst Drew Ranieri maintains $Stryker Corp(SYK.US)$ with a hold rating, and adjusts the target price from $345 to $350.According to TipRanks data, the analyst has a success rate of 39
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $372
BTIG analyst Ryan Zimmerman maintains $Stryker Corp(SYK.US)$ with a buy rating, and adjusts the target price from $369 to $372.According to TipRanks data, the analyst has a success rate of 46.6% and
Express News | Stryker Completes Acquisition of Artelon, Inc.
Stryker (NYSE:SYK) Could Easily Take On More Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to
Express News | Stryker Corp : Btig Raises Target Price to $372 From $369
Morgan Stanley Adjusts Price Target on Stryker to $350 From $345, Maintains Equalweight Rating
Stryker (SYK) has an average outperform rating and a price target range of $242 to $406, according to analysts polled by Capital IQ.Price: 337.57, Change: -1.80, Percent Change: -0.53
Here's Why Stryker (NYSE:SYK) Has Caught The Eye Of Investors
3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now
Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit
Goldman Sachs Adjusts Price Target on Stryker to $364 From $372
Stryker (SYK) has an average outperform rating and a price target range of $242 to $406, according to analysts polled by Capital IQ.
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 4.1% on an annualized basis producing an average annual return of 15.02%. Currently, Stryker has a market capitalization of $12
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
Investors Appear Satisfied With Stryker Corporation's (NYSE:SYK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Stryker Corporation (NYSE:SYK) as a stock to avoid entirely with its 37.6x
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Should You Investigate Stryker Corporation (NYSE:SYK) At US$334?
Stryker Is Maintained at Outperform by Evercore ISI Group
Stryker Is Maintained at Outperform by Evercore ISI Group